Masayuki Takeda
University of Yamanashi Hospital · 680 works · 17,423 citations · h-index 66
Top works
- Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
- 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE
- Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score
- Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
- Laparoscopic adrenalectomy for primary aldosteronism: report of initial ten cases.
- Laparoscopic Adrenalectomy for Primary Aldosteronism: A New Operative Method
- Learning curve and conversion to open surgery in cases of laparoscopic adrenalectomy and nephrectomy.
- Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
- LEARNING CURVE AND CONVERSION TO OPEN SURGERY IN CASES OF LAPAROSCOPIC ADRENALECTOMY AND NEPHRECTOMY
- Experience with 17 Cases of Laparoscopic Adrenalectomy: Use of Ultrasonic Aspirator and Argon Beam Coagulator
- Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
- Small In-Frame Deletion in the Epidermal Growth Factor Receptor as a Target for ZD6474
- Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods.
- Retroperitoneal Laparoscopic Adrenalectomy for Functioning Adrenal Tumors: Comparison With Conventional Transperitoneal Laparoscopic Adrenalectomy
- First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
- Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
- Effects of nitric oxide on human and canine prostates
- Clinical guidelines for overactive bladder
- Pharmacological evidence of distinct oci‐adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery
- Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly